Korean J Intern Med.  2021 Sep;36(5):1260. 10.3904/kjim.2020.549.e1.

Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma

Affiliations
  • 1Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea
  • 2Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea
  • 3Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
  • 4Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
  • 5Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea
  • 6Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  • 7Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea
  • 8Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
  • 9Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
  • 10Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
  • 11Division of Allergy, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 12Department of Internal Medicine, Chung-Ang University H.C.S. Hyundae Hospital, Namyangju, Korea

Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error